Real-world outcomes of dupilumab therapy in moderate-to-severe atopic dermatitis patients: an observational retrospective study in Gulf countries
Dupilumab demonstrated sustained clinical improvements and favorable safety. These findings reinforce the results of previous real-world studies and Randomized Controlled Trials.
Authors
- Waqas S. Abdulwahhab (ORCID: https://orcid.org/0000-0002-1234-704X)
- Ahmed Barakat (ORCID: https://orcid.org/0000-0002-7742-7059)
- Shrirang Bichu (ORCID: https://orcid.org/0009-0001-1983-0210)
- Yousef Binamer (ORCID: https://orcid.org/0000-0003-0948-7102)
- Monira Abdullah Alnasser
- Zubair Wani (ORCID: https://orcid.org/0009-0008-6455-579X)
- Mohamed Zahir Chouikrat (ORCID: https://orcid.org/0000-0002-6412-3558)
- Mohammed Alajlan (ORCID: https://orcid.org/0009-0007-5497-0458)
- Mohammed Hafiz
- Monica Fahmy (ORCID: https://orcid.org/0000-0003-4905-8986)
- Amani AlFalasi
- Sahar Chmayse
- Ghada Elmorshidy (ORCID: https://orcid.org/0009-0003-5825-9031)
- Dina Jabaji
- Fatima BinSayyar (ORCID: https://orcid.org/0009-0000-6702-4486)
- Duaa Gadalla (ORCID: https://orcid.org/0009-0001-5002-1251)
Institutions
- Dubai Health Authority (AE)
- Alfaisal University (SA)
- Qassim University (SA)
- Oasis Hospital (AE)
- King Faisal Specialist Hospital & Research Centre (SA)
- King Fahd Medical City (SA)
- Dubai Hospital (AE)
- University of Sharjah (AE)
- University of Jeddah (SA)
- Dubai Medical College (AE)
- University of Business and Technology (SA)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1080/09546634.2025.2572650
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00